Cargando…
Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene
Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen receptor-T (CAR-T) cells, are only efficient in a small proportion of tumor patients. One of the major reasons for this is the lack of immune cell infiltration and activation in the tumor microenvironment (TME). Recent...
Autores principales: | Cao, Dujuan, Song, Qianqian, Li, Junqi, Chard Dunmall, Louisa S., Jiang, Yuanyuan, Qin, Bin, Wang, Jianyao, Guo, Haoran, Cheng, Zhenguo, Wang, Zhimin, Lemoine, Nicholas R., Lu, Shuangshuang, Wang, Yaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114156/ https://www.ncbi.nlm.nih.gov/pubmed/35615262 http://dx.doi.org/10.1016/j.omto.2022.04.008 |
Ejemplares similares
-
Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
por: Zhou, Wenping, et al.
Publicado: (2023) -
Natural products targeting glycolysis in cancer
por: Zhao, Yuanyuan, et al.
Publicado: (2022) -
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022) -
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
por: Marelli, Giulia, et al.
Publicado: (2021) -
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
por: Sun, Yijie, et al.
Publicado: (2022)